Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say

Hims & Hers Health's ZAVA acquisition "adds a lot of regulatory complexity and will require substantial resources to get up and running," the analyst wrote. The back half of the year could be even more challenging for the company. As the investment cycle unfolds, cash flow generation remains lmiited in the near term. Needham: Hims & Hers Health reported revenue of $544.8 million, missing consensus of $551.7 million, MacDonald said. The company's average monthly revenue per subscriber came in at $74 in the q ...